News Sentiment

BRTX sentiment intelligence

BioRestorative Therapies Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 59 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.33 Week of 17 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 50

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-3.2% over one week, -18.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Leadership shake-up at Biorestorative Therapies (NASDAQ: BRTX) and new CEO

Market Reaction

Balanced read

58/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction -3.2% Price reacting lower
Trend fit Trend inactive -18.4% over four weeks
Fair value -76.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 39
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 50
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 14
Market source 12
Stock Titan 10
GlobeNewswire 4
Moomoo 3
Investing.com 3
Quiver Quantitative 3
simplywall.st 3

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 17
Deals and strategy 4
Balance sheet 3
Analyst action 2
Macro sensitivity 2
Regulatory and legal 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 59
Stock Titan Direct company coverage

Leadership shake-up at Biorestorative Therapies (NASDAQ: BRTX) and new CEO

BioRestorative Therapies (BRTX) has undergone a significant leadership change, with President, CEO, and Chairman Lance Alstodt and CFO Robert Kristal resigning, claiming "Good Reason" due to an alleged Change in Control and seeking approximately $2.85 million in severance, which

Tone
Negative 39/100
Event
Market update
Published
16 Jul 2026 21:09
Source
Stock Titan
www.marketscreener.com Direct company coverage

BioRestorative Therapies, Inc. Announces CFO Changes, Effective July 13, 2026

BioRestorative Therapies, Inc. announced the resignation of CFO Robert Kristal, effective July 13, 2026, citing "Good Reason" due to a Change in Control related to Board changes in June 2026. The Board disputes the validity of the claims and has initiated an investigation into Kr

Tone
Negative 28/100
Event
Regulatory and legal
Published
16 Jul 2026 17:30
Source
www.marketscreener.com
TradingView Direct company coverage

Price to book forward of BioRestorative Therapies, Inc. – GETTEX:9OF

This article provides the "Price to book forward" value for BioRestorative Therapies, Inc. (GETTEX:9OF) as part of its financial data overview on TradingView. It indicates that the current period value is available, along with change and percentage change details, and clarifies t

Tone
Neutral 50/100
Event
Market update
Published
07 Jul 2026 20:13
Source
TradingView
marketscreener.com Direct company coverage

BioRestorative Therapies, Inc.'s Equity Buyback announced on August 12, 2025, has expired.

BioRestorative Therapies, Inc. announced that its equity buyback program, originally unveiled on August 12, 2025, has officially expired. The plan concluded on June 16, 2026. This information was reported on June 15, 2026, according to S&P Capital IQ.

Tone
Negative 33/100
Event
Capital return
Published
01 Jul 2026 12:10
Source
marketscreener.com
TradingView Direct company coverage

Enterprise value to EBITDA forward of BioRestorative Therapies, Inc. – NASDAQ:BRTX

This article displays financial information for BioRestorative Therapies, Inc. (NASDAQ: BRTX) on TradingView, specifically focusing on its enterprise value to EBITDA forward metric. The content highlights the company's financial overview within the health technology sector.

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 00:41
Source
TradingView
TradingView Direct company coverage

Price to book forward of BioRestorative Therapies, Inc. – NASDAQ:BRTX

This article provides access to the "Price to book forward" financial metric for BioRestorative Therapies, Inc. (NASDAQ: BRTX) on TradingView. It highlights that the market was closed at the time of viewing, with no trades recorded. The content primarily serves as a finance porta

Tone
Neutral 50/100
Event
Market update
Published
28 Jun 2026 23:39
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of BioRestorative Therapies, Inc. – TRADEGATE:9OF

This article provides financial information for BioRestorative Therapies, Inc. (TRADEGATE:9OF), specifically focusing on its forward price to earnings. The content indicates that for the specified period, the value is listed, but no trades were observed, and the market was closed

Tone
Neutral 50/100
Event
Earnings
Published
28 Jun 2026 08:41
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of BioRestorative Therapies, Inc. – NASDAQ:BRTX

This article provides financial information for BioRestorative Therapies, Inc. (BRTX) on TradingView, specifically focusing on its enterprise value to revenue forward. It indicates the stock is listed on Nasdaq and highlights that the market is currently closed with no trades. Th

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 11:10
Source
TradingView
TradingView Direct company coverage

Price to sales forward of BioRestorative Therapies, Inc. – TRADEGATE:9OF

The article provides financial information for BioRestorative Therapies, Inc. (TRADEGATE:9OF), specifically its forward price-to-sales ratio. It's hosted on TradingView, a financial platform offering various market data and analysis tools for stocks, ETFs, crypto, and more.

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 09:10
Source
TradingView
TradingView Direct company coverage

Price to book forward of BioRestorative Therapies, Inc. – TRADEGATE:9OF

This article provides "Price to book forward" information for BioRestorative Therapies, Inc. (TRADEGATE:9OF) as part of its financial data. The content primarily lists navigation and footer links from the TradingView platform, indicating that the core financial data is what the p

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 04:39
Source
TradingView
TradingView Direct company coverage

BioRestorative Therapies, Inc. Actuals & Estimates (NASDAQ:BRTX)

This article from TradingView provides a comprehensive overview of BioRestorative Therapies, Inc. (NASDAQ: BRTX) stock, including its current price, historical performance, analyst forecasts, and key financial metrics. It highlights the stock's significant decline over the past y

Tone
Negative 29/100
Event
Analyst action
Published
26 Jun 2026 12:39
Source
TradingView
Moomoo Direct company coverage

BioRestorative Therapies Announces Completion of BRTX-100 Manufacturing for Phase 2 Clinical Trial

BioRestorative Therapies has completed the manufacturing of its lead clinical product, BRTX-100, which is intended for a Phase 2 clinical trial targeting chronic lumbar disc disease (CLDD). This completion marks a significant advancement towards initiating the trial, pending all

Tone
Positive 78/100
Event
Market update
Published
26 Jun 2026 10:39
Source
Moomoo
Market source Direct company coverage

BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform

BioRestorative Therapies, Inc. (Nasdaq: BRTX) has announced the successful completion of manufacturing for its BRTX-100 Phase 2 clinical trial supply. This achievement signifies a critical milestone for their lead cell therapy candidate for chronic lumbar disc disease and undersc

Tone
Positive 82/100
Event
Macro sensitivity
Published
25 Jun 2026 22:10
Source
Market source
TradingView Direct company coverage

BioRestorative Therapies, Inc. Actuals & Estimates (DUS:9OF)

This article provides financial actuals and estimates for BioRestorative Therapies, Inc. (9OF) traded on the Dusseldorf Stock Exchange. It includes analyst price targets, historical stock performance, earnings reports, revenue figures, net income, and current employee count, alon

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 19:11
Source
TradingView
TradingView Direct company coverage

A3C9XF Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for BioRestorative Therapies, Inc. (A3C9XF), discussing analyst opinions on its future price, historical performance, and key financial metrics. It details the company's current stock price, market capitalization, earnings, revenu

Tone
Positive 63/100
Event
Analyst action
Published
25 Jun 2026 18:10
Source
TradingView
Stock Titan Direct company coverage

BioRestorative finishes BRTX-100 Phase 2 supply in-house

BioRestorative Therapies (Nasdaq:BRTX) has completed manufacturing the clinical supply for its BRTX-100 Phase 2 trial, a cell therapy aimed at chronic lumbar disc disease. This milestone showcases the company's vertically integrated regenerative medicine platform and its in-house

Tone
Positive 76/100
Event
Macro sensitivity
Published
25 Jun 2026 12:41
Source
Stock Titan
TradingKey Direct company coverage

BioRestorative Therapies Inc (BRTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of BioRestorative Therapies Inc (BRTX), detailing its current price momentum score, support and resistance levels, and signals from various technical indicators and moving averages. While the stock is suitable for range-bound swing tradi

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 06:39
Source
TradingKey
Moomoo Direct company coverage

Biorestorative Therapies Company Profile & Introduction

This entry is a company profile and introduction for Biorestorative Therapies. It provides an overview of the company, which is involved in Biorestorative Therapies.

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 08:40
Source
Moomoo
Stock Titan Direct company coverage

BioRestorative Therapies (NASDAQ: BRTX) director Dhaliwal files clean Form 3

Jatinder Dhaliwal, a director at BioRestorative Therapies (NASDAQ: BRTX), has filed an initial statement of beneficial ownership (Form 3) with the SEC. This filing indicates no reportable transactions or derivative positions, meaning there were no recent insider trades disclosed

Tone
Neutral 50/100
Event
Market update
Published
19 Jun 2026 04:40
Source
Stock Titan
Stock Titan Direct company coverage

Director Mika Grasso files initial Form 3 at BioRestorative (BRTX)

Mika Grasso, a director at BioRestorative Therapies, Inc. (BRTX), has filed an initial Form 3, which is a mandatory statement of beneficial ownership for new insiders. This filing explicitly states that Grasso is a director and does not report any insider buy, sell, or other tran

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 20:39
Source
Stock Titan
The Manila Times Direct company coverage

BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth

BioRestorative Therapies has appointed Zachary Smith as Vice President of its Biocosmeceuticals Division to accelerate commercial expansion and strategic growth. Smith, an accomplished commercial aesthetics veteran, will lead revenue growth initiatives and sales channel expansion

Tone
Positive 71/100
Event
Earnings
Published
18 Jun 2026 12:11
Source
The Manila Times
GlobeNewswire Direct company coverage

BioRestorative Therapies Strengthens Leadership with

BioRestorative Therapies, Inc. has appointed Zachary Smith as Vice President of its Biocosmeceuticals Division to accelerate commercial expansion and strategic growth in the regenerative aesthetics and advanced skincare market. Smith brings over 16 years of experience in medical

Tone
Positive 72/100
Event
Market update
Published
18 Jun 2026 08:15
Source
GlobeNewswire
Stock Titan Direct company coverage

BioRestorative Therapies (BRTX) director Katharyn Field files initial Form 3

BioRestorative Therapies director Katharyn Field has filed an initial Statement of Beneficial Ownership on Form 3 with the SEC. This filing identifies her solely as a director, not an officer or a ten percent owner, and indicates no specific transactions or current securities hol

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 20:40
Source
Stock Titan
TradingKey Direct company coverage

BioRestorative Therapies Inc (BRTX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides historical data on dividends and stock splits for BioRestorative Therapies Inc (BRTX), showing that the company has not distributed any dividends over the past five years and has no recorded stock split events. It also includes current stock information such

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 06:39
Source
TradingKey
TradingView Direct company coverage

Long term debt to total equity ratio of BioRestorative Therapies, Inc. – DUS:9OF

This article displays the long-term debt to total equity ratio for BioRestorative Therapies, Inc. (DUS:9OF) on the TradingView platform. It highlights that the market was closed with no trades at the time of viewing. The content confirms that the financial data is 'Made by humans

Tone
Neutral 50/100
Event
Balance sheet
Published
17 Jun 2026 04:40
Source
TradingView
TradingView Direct company coverage

BioRestorative Therapies, Inc. Cash Flow – DUS:9OF

BioRestorative Therapies, Inc. (DUS:9OF) reported Q1 2026 free cash flow of -€3.30 million. For the full year 2025, the company's free cash flow was -€9.28 million, with operating cash flow at -€9.19 million. This financial overview provides insight into the company's cash flow f

Tone
Neutral 50/100
Event
Balance sheet
Published
16 Jun 2026 16:39
Source
TradingView